Stony Brook University

Planet Classroom Presents Net Zero Speaks with Katharine Hayhoe: A Thought-Provoking Dialogue on Climate Solutions

Retrieved on: 
Mercredi, mai 1, 2024
Education, Siddhant, United Nations, Climate change, The Nature Conservancy, Language, Interview, Nature, Stony Brook University, Time (magazine), Life, Texas Tech University, Science, Climate, Recycling

NEW YORK, May 1, 2024 /PRNewswire-PRWeb/ -- Now Streaming on Planet Classroom is the latest addition to its acclaimed Net Zero video and podcast series: Net Zero Speaks with Katharine Hayhoe. This stimulating installment, curated by Planet Classroom and the Protect Our Planet Movement, features a captivating exchange between Climate Activist Siddhant Desai and renowned atmospheric scientist Katharine Hayhoe.

Key Points: 
  • NEW YORK, May 1, 2024 /PRNewswire-PRWeb/ -- Now Streaming on Planet Classroom is the latest addition to its acclaimed Net Zero video and podcast series: Net Zero Speaks with Katharine Hayhoe.
  • This stimulating installment, curated by Planet Classroom and the Protect Our Planet Movement, features a captivating exchange between Climate Activist Siddhant Desai and renowned atmospheric scientist Katharine Hayhoe.
  • For audiences seeking insights into climate action and sustainability, Net Zero Speaks with Katharine Hayhoe offers invaluable perspectives and actionable takeaways.
  • The Net Zero Video and Podcast series is produced by the Planet Classroom Network and the Protect Our Planet Movement.

Canon U.S.A. Supports Japan Center Essay Competition at Stony Brook University

Retrieved on: 
Mardi, avril 23, 2024
Education, Consulate, Essay, Stony Brook University, Partnership, History, Culture, Politics, Student, Japan Center, Philosophy, Management

The essay competition, organized by the Japan Center at Stony Brook, honors students for work that demonstrates their awareness and understanding of the Japanese culture.

Key Points: 
  • The essay competition, organized by the Japan Center at Stony Brook, honors students for work that demonstrates their awareness and understanding of the Japanese culture.
  • "We are proud to partner with Canon U.S.A. on the essay competition, providing students with the opportunity to develop a better understanding of cultural activities related to Japan," said Dr. Iwao Ojima, the President of Japan Center at Stony Brook University.
  • Canon U.S.A., Inc. and the Japan Center at Stony Brook University have a longstanding partnership, which began in 2005 with former president and chief executive officer of Canon U.S.A., Inc., the late Mr. Kinya Uchida.
  • Attendees included the award-winning students, and representatives from the Japan Center at Stony Brook, Canon U.S.A., Inc., and Consulate General of Japan in New York.

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

Retrieved on: 
Jeudi, mars 28, 2024
Stony Brook University, University, Adenocarcinoma, PRRT, Patient, Mayo Clinic, Sale, Bristol Myers Squibb, Society, IND, European Journal, Therapy, SPECT, Melanoma, Research, MC1R, Fortis Healthcare, SNMMI, Cohort, Trial of the century, Radiopharmaceutical, Cancer, Nivolumab, Safety, CATX, PSMA, Food, LNTH, BMY, IIT, Prostate cancer, Nuclear medicine, EANM, NETS, Institute of technology, Diagnosis, Glomus tumor, PET, Prostate, Small business, Bangladesh Technical Education Board, Molecular imaging, Pharmaceutical industry

SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today provided a business update and announced fiscal year 2023 financial results for the period ended December 31, 2023.

Key Points: 
  • SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today provided a business update and announced fiscal year 2023 financial results for the period ended December 31, 2023.
  • “We made tremendous progress during 2023 in building a fully integrated radiopharmaceuticals company dedicated to advancing potentially best- or first-in-class alpha-particle therapies,” said Thijs Spoor, Perspective Therapeutics' CEO.
  • Preliminary results from Cohorts 1 and 2 of the Phase 1/2a trial are expected in the third quarter 2024.
  • In January 2024, Perspective Therapeutics entered into strategic agreements with Lantheus Holdings, Inc. and its affiliates (“Lantheus”) (NASDAQ: LNTH).

Verita Announces Two Strategic Hires

Retrieved on: 
Jeudi, février 29, 2024
AICPA, Real estate, Fire, Certified safety professional, Corps, ARM, Stony Brook University, MOAB, MGU, OSHA, ASP, Safety, Tufts University, ASSP, Economics, Risk control, Hospitality, Engineer, ASCE, Insurance, Environment

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Verita (Verita CSG, Inc.), a visionary Managing General Underwriting (MGU) company, announced today that Victor Sordillo and Glen O’Connor have joined the organization.

Key Points: 
  • NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Verita (Verita CSG, Inc.), a visionary Managing General Underwriting (MGU) company, announced today that Victor Sordillo and Glen O’Connor have joined the organization.
  • O’Connor brings more than 20 years of experience in Risk Control to his new position at Verita.
  • Sordillo, Director of Risk Advisory Services, Verita, commented: “I am honored to join the Verita team of high performing professionals dedicated to bringing innovation to the insurance industry.
  • This involves harnessing advanced technology overlapped with human behavior analysis and the environment to protect people and property.”
    O’Connor, Deputy Director of Risk Advisory Services, Verita, added: “I am truly excited to be working with Verita.

Students graduating with a Rutgers MBA benefit from robust New Jersey job market

Retrieved on: 
Jeudi, février 22, 2024
University of Mumbai, Rutgers University, Stony Brook University, Multimedia, Garden State, Marketing, Health, Dell, Johnson & Johnson, Sood, MBA, Curriculum, Food, Mathematics, Learning, Garden, Mentorship, City, Ethicon, Military, Employment, Dell Technologies, Pace University, Finance, Telecommunications, Financial Times, Software, Student, Management

NEWARK, N.J., Feb. 22, 2024 /PRNewswire/ -- With a booming economy in the state of New Jersey and the close proximity to New York City, Rutgers Business School  MBA graduates are taking advantage of a robust job market.

Key Points: 
  • NEWARK, N.J., Feb. 22, 2024 /PRNewswire/ -- With a booming economy in the state of New Jersey and the close proximity to New York City, Rutgers Business School MBA graduates are taking advantage of a robust job market.
  • Most Rutgers Full-Time MBA graduates find a job in New Jersey in part because it has experienced some of the fastest job growth of any state in the Northeast.
  • "The unsung hero is the New Jersey economy," said Dean Vera, assistant dean and director, MBA Office of Career Management at Rutgers Business School.
  • The median starting base salary after graduation (in 2022) for full-time Rutgers MBA students was $113,500 according to Vera.

New Research Shows Minimally Invasive Therapy (Middle Meningeal Artery Embolization) is Effective in Treating Chronic Subdural Hematoma

Retrieved on: 
Lundi, février 12, 2024
Subdural space, Recurrence, Doctor of Philosophy, Neurosurgery, Blood, Arm, STEM, FDA, U.S. FDA, Skull, Leg, BALT, Society, University, Disease, Stony Brook University, MMAE, Patient, MPH, Epidural hematoma, Mortality, Research, Brain, Birth control

FAIRFAX, Va., Feb. 12, 2024 /PRNewswire/ -- The Society of Neurolnterventional Surgery (SNIS) is acknowledging middle meningeal artery embolization (MMAE) as a beneficial adjunctive treatment for chronic subdural hematoma in light of new research. The minimally invasive MMAE procedure significantly reduced the failure rates of traditional surgical and non-surgical management strategies without an increased rate of serious neurological complications.

Key Points: 
  • Chronic subdural hematoma refers to the gradual accumulation of blood over the surface of the brain.
  • As the U.S. population continues to age, studies show that chronic subdural hematomas may be the most prevalent neurosurgical diagnosis that requires treatment within the next decade.
  • However, an average of 10% to 30% of patients experience recurrence of chronic subdural hematoma after surgery, often necessitating reoperation.
  • Chronic subdural hematoma is an exceedingly common problem, and these findings will be relevant to a large population of patients.

An Author and a Gentleman: Dr. Hugh Finch Releases "Arctic Revelation" - A Thrilling Blend of History, Mystery, and Philanthropy

Retrieved on: 
Lundi, février 12, 2024
Eye, School, Mental health, Psychology, Emotion, Dentistry, Kirkus Reviews, The Surgeon, Mental disorder, Organic, Blinking, History, Death, Stony Brook University, Amazon, Child, Trauma, National Alliance

GLASTONBURY, Conn., Feb. 12, 2024 /PRNewswire/ -- Author, educator, and practitioner Dr. Hugh Finch announced the release of his unique fiction thriller, "Arctic Revelation: A Thousand Lifetimes in the Blink of an Eye." An international tour-de-force culminating in a stunning 'whodunit' conclusion that has kept even the most seasoned readers and critics captivated and guessing right till the end.

Key Points: 
  • "...this is a thriller…the reader can't resist going forward to find out how it all connects ...the heady concept, action and danger pay dividends."
  • from Kirkus Reviews
    "...a true masterpiece" and "...a mind-blowing psychological thriller" from critics at OnlineBookClub.org and Discovery Reviews.
  • Dr. Finch reflects, "The true reward in accomplishing something great is when you do it for something far greater than yourself.
  • Dr. Finch is committed to paying it forward by using his story to support mental health awareness.

Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform

Retrieved on: 
Jeudi, février 1, 2024
Stony Brook University, Toxicity, National Cancer Institute, Research, Riitta Jallinoja, NIH, CB7, CATX, Patient, Safety, Diagnosis, Adma, CEA, Ligand, Therapy, Radiation, Journal, Assistant professor, Cancer, Neoplasm, Radiology, Bangladesh Technical Education Board, Radioactive decay, Nuclear medicine, Vaccine

This antibody is chemically modified to include the CB7 chemical entity and accumulates over time at the tumor site.

Key Points: 
  • This antibody is chemically modified to include the CB7 chemical entity and accumulates over time at the tumor site.
  • Then, a radionuclide held tightly by Perspective’s proprietary chelator attached to an Adma group is administered.
  • The research conducted at Stony Brook University refines the understanding of the potential of the proprietary CB7-Adma pre-targeting platform for image-guided radionuclide therapy for oncology.
  • The technology was first described by Stony Brook University researchers, Jacob L. Houghton, Ph.D. and Vilma I.J.

Intelligent Product Solutions Names Jan Niewiadomski to CTO

Retrieved on: 
Mardi, janvier 30, 2024
Software, Growth, Electronics, IPS, BAE Systems, Mechanical, Electricity, MBA, Stony Brook University, Electrical engineering, PMP, Systems architecture, Embedded software, Management

HAUPPAUGE, N.Y., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Intelligent Product Solutions (IPS), an award-winning global product design firm, today announced that Jan Niewiadomski was named Chief Technology Officer.

Key Points: 
  • HAUPPAUGE, N.Y., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Intelligent Product Solutions (IPS), an award-winning global product design firm, today announced that Jan Niewiadomski was named Chief Technology Officer.
  • With deep experience in medical devices, defense, and international business, Jan Niewiadomski was promoted to Chief Technology Officer.
  • Ralph Cassara was named IPS Fellow and Digital Health Leader, heading up IPS’ practice focused on digital health and medtech product design.
  • “Their combined leadership positions us strongly for the next phase of growth at IPS, leveraging their deep expertise in product design and innovation.”
    Founded in 2007, Intelligent Product Solutions’ breadth of capabilities and number of employees has grown to a staff of more than 100 product designers and engineers, providing full-service end-to-end development.

SightMD New York Welcomes Clearview Eye Surgery to It's Expert Team

Retrieved on: 
Jeudi, janvier 25, 2024
Family, Patient, Cataract, United States Army, Blepharoplasty, Health, Contact, Trust, Stony Brook University, Partnership, Retina, Eye, Retinal, Communication, Diabetic retinopathy, PHD, Macular degeneration, Strabismus, Suite, Acquisition, Bachelor of Science, Glaucoma, DSM-IV codes, OD, Gettysburg College, Diagnosis, Physician

HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery. Through this strategic partnership Clearview's practice locations at 1825 Riverside Drive, Suite 1B New York, NY 10034, 1200 Waters Place, Suite 304 Bronx, NY 10461 and 132-15 41st Avenue CC Flushing , NY 11355 will expand SightMD's presence by adding three locations and five providers, growing SightMD's current footprint to 40+ locations and 85+ providers across New York.

Key Points: 
  • HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery.
  • - Dr. John J. Kim, Founder of Clearview Eye Surgery
    "We are excited to welcome Clearview Eye Surgery into the SightMD family.
  • Clearview Eye Surgery is dedicated to providing state of the art, professional and personalized eye care to all of our patients to ensure the best possible outcome.
  • Thousands of people have trusted their award-winning team with their families' eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD.